ATE456651T1 - Metalloprotease mit aggrecanase-aktivität - Google Patents

Metalloprotease mit aggrecanase-aktivität

Info

Publication number
ATE456651T1
ATE456651T1 AT00974894T AT00974894T ATE456651T1 AT E456651 T1 ATE456651 T1 AT E456651T1 AT 00974894 T AT00974894 T AT 00974894T AT 00974894 T AT00974894 T AT 00974894T AT E456651 T1 ATE456651 T1 AT E456651T1
Authority
AT
Austria
Prior art keywords
metalloprotease
aggrecanase activity
inhibiting
aggrecanase
activity
Prior art date
Application number
AT00974894T
Other languages
English (en)
Inventor
Noboru Yamaji
Kouichi Nishimura
Kunitake Abe
Osamu Ohara
Takahiro Nagase
Nobuo Nomura
Original Assignee
Astellas Pharma Inc
Kazusa Dna Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc, Kazusa Dna Res Inst filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE456651T1 publication Critical patent/ATE456651T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT00974894T 1999-11-11 2000-11-10 Metalloprotease mit aggrecanase-aktivität ATE456651T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP32174099 1999-11-11
JP2000144020 2000-05-16
PCT/JP2000/007917 WO2001034785A1 (fr) 1999-11-11 2000-11-10 Nouvelle metalloprotease presentant une activite aggrecanase

Publications (1)

Publication Number Publication Date
ATE456651T1 true ATE456651T1 (de) 2010-02-15

Family

ID=26570581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974894T ATE456651T1 (de) 1999-11-11 2000-11-10 Metalloprotease mit aggrecanase-aktivität

Country Status (8)

Country Link
US (2) US6716613B1 (de)
EP (1) EP1234875B1 (de)
JP (1) JP3356771B2 (de)
AT (1) ATE456651T1 (de)
AU (1) AU1305501A (de)
DE (1) DE60043783D1 (de)
ES (1) ES2338210T3 (de)
WO (1) WO2001034785A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026949A2 (en) * 2000-09-29 2002-04-04 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
ES2212695B1 (es) * 2001-09-14 2005-10-16 Universidad De Oviedo Procedimiento de identificacion de la proteina humana adamts-13.
ES2211256B1 (es) * 2001-09-28 2005-10-16 Universidad De Oviedo. Procedimiento de identificacion de la proteina humana adamts-19.
ES2204250B1 (es) * 2001-09-24 2005-08-16 Universidad De Oviedo Procedimiento de identificacion de la proteina humana adamts-16.
ES2205989B1 (es) * 2001-09-24 2005-08-16 Universidad De Oviedo Procedimiento de identificacion de la proteina humana adamts-15.
ES2201874B1 (es) * 2001-09-24 2005-05-16 Univesidad De Oviedo Procedimiento de identificacion de la proteina humana adamts-17.
JP2003180384A (ja) * 2001-09-24 2003-07-02 Daiichi Fine Chemical Co Ltd Ａｄａｍｔｓ−１５，−１６，−１７，−１８及び−１９
ES2213428B1 (es) * 2001-09-25 2005-11-16 Universidad De Oviedo. Procedimiento de identificacion de la proteina humana adamts-19.
WO2005103287A1 (en) * 2004-04-16 2005-11-03 Wyeth Truncated adamts molecules
US8003331B2 (en) 2005-08-12 2011-08-23 Astellas Pharma Inc. Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein
CA2598893C (en) 2006-10-11 2012-04-10 Astellas Pharma Inc. Eml4-alk fusion gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296766C (en) * 1997-07-25 2010-03-16 Du Pont Pharmaceuticals Company Aggrecan degrading metallo proteases
CA2411971A1 (en) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Proteases
WO2002026949A2 (en) * 2000-09-29 2002-04-04 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same

Also Published As

Publication number Publication date
ES2338210T3 (es) 2010-05-05
AU1305501A (en) 2001-06-06
EP1234875A1 (de) 2002-08-28
EP1234875B1 (de) 2010-01-27
EP1234875A4 (de) 2004-03-24
US20040142445A1 (en) 2004-07-22
WO2001034785A1 (fr) 2001-05-17
JP3356771B2 (ja) 2002-12-16
US6716613B1 (en) 2004-04-06
DE60043783D1 (de) 2010-03-18

Similar Documents

Publication Publication Date Title
ATE347901T1 (de) Exendine zur glucagon suppression
DK1487416T3 (da) Lægemiddelmikropartikler
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
HK1097828A1 (en) 42-0-alkoxyalkyl rapamycin derivatives and compositions comprising same
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DE60043587D1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
DE60043783D1 (de) Metalloprotease mit aggrecanase-aktivität
PT991654E (pt) Novos derivados de 2-(iminometil)amino-fenilo sua preparacao sua aplicacao como medicamentos e composicoes farmaceuticas que os contem
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
IT1308678B1 (it) Siringa per infusione di farmaci.
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
BR0208593A (pt) método para o tratamento de um mamìfero, composto, e, composição farmacêutica
DK1602669T3 (da) Antistof mod et tumor-specifikt antigen som target
DE3879985T2 (de) Anticonvulsive agenzien.
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
CY1110278T1 (el) Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
ES1032126Y (es) Juego esterilizable para la autoinyeccion de drogas.
DK1330253T3 (da) Anvendelse af bioaktiv fraktion af kourindestillat ("Go-mutra") som en biofremmer for antiinfektionsmidler, anticancermidler og næringsmidler
IT1307258B1 (it) Apparecchio per infusione prolungata di farmaci.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1234875

Country of ref document: EP